Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular Hypertension (OH)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Large-scale testing (Phase 3)Study completedNCT02822729
What this trial is testing

A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 125
Testing effectiveness (Phase 2)Study completedNCT01481077
What this trial is testing

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension (OH)
Mati Therapeutics Inc. 77
Large-scale testing (Phase 3)WithdrawnNCT01721707
What this trial is testing

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Adapt Produtos Oftalmológicos Ltda.
Testing effectiveness (Phase 2)Study completedNCT00967811
What this trial is testing

Different Formulations of the L-PPDS in Subjects With OH or OAG

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc. 83
Large-scale testing (Phase 3)Study completedNCT02822742
What this trial is testing

A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 26
Post-approval studies (Phase 4)Study completedNCT00647101
What this trial is testing

Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Large-scale testing (Phase 3)Looking for participantsNCT07661329
What this trial is testing

Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OH)
YS Life Science Co., Ltd. 600
Testing effectiveness (Phase 2)Study completedNCT01481051
What this trial is testing

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension (OH)
Mati Therapeutics Inc. 57
Large-scale testing (Phase 3)Study completedNCT00383019
What this trial is testing

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

Who this might be right for
GlaucomaOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 300
Testing effectiveness (Phase 2)Study completedNCT00821002
What this trial is testing

Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Mati Therapeutics Inc. 32
Not applicableLooking for participantsNCT07400926
What this trial is testing

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Who this might be right for
Open Angle Glaucoma (OAG)Ocular Hypertension (OH)
Glaukos Corporation 30
Testing effectiveness (Phase 2)Study completedNCT01037036
What this trial is testing

The L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

Who this might be right for
Ocular HypertensionOpen-Angle Glaucoma
Mati Therapeutics Inc. 15
Not applicableUnknownNCT01084902
What this trial is testing

Efficacy Comparison of Xalatan and Azopt on POAG and OH

Who this might be right for
Ocular Hypertension
Peking University First Hospital 130
Not applicableStudy completedNCT06689696
What this trial is testing

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

Who this might be right for
GlaucomaGLAUCOMA 1, OPEN ANGLE, D (Disorder)Ocular Hypertension+8 more
Smartlens, Inc. 86
Post-approval studies (Phase 4)Ended earlyNCT00047606
What this trial is testing

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 84
Post-approval studies (Phase 4)Study completedNCT00143208
What this trial is testing

Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

Who this might be right for
GlaucomaOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 250
Large-scale testing (Phase 3)Study completedNCT01357616
What this trial is testing

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 328
Testing effectiveness (Phase 2)Study completedNCT00846989
What this trial is testing

Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Novartis Pharmaceuticals 276
Early research (Phase 1)Active Not RecruitingNCT06964061
What this trial is testing

Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open Angle Glaucoma (OAG)Ocular Hypertension (OH)
PolyActiva Pty Ltd 12
Post-approval studies (Phase 4)Study completedNCT05857267
What this trial is testing

Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Laboratorios Poen 84
Next Page